AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicus Pharma Ltd. Director's Dealing 2025

Feb 10, 2025

34562_dirs_2025-02-10_e39272f1-4b30-46ab-ad32-a85f700d9d19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2024-12-31

Reporting Person: Bokhari Raza (Director, Chief Executive Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares, no par value ("Common Shares")	793173	Indirect

Footnotes

F1: This amendment is being filed to correct the number of Common Shares reported to be indirectly held by the Reporting Person.

F2: Held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.